Test Price
1,100 AED✅ Home Collection Available
ALL Panel Deletion/Duplication Detection in UAE | 1100 AED
Executive Summary & Core Metrics
Executive Summary: This high‑precision MLPA panel delivers 99.9% diagnostic sensitivity for clinically significant copy‑number variations in acute lymphoblastic leukemia. Backed by ISO‑certified processing, post‑test telephonic guidance, and direct insurance verification via WhatsApp (+971 54 548 8731). Price: 1,100 AED. Turnaround time: 9–10 working days.
Test Overview & Methodology
The ALL Panel Deletion/Duplication Detection test employs multiplex ligation‑dependent probe amplification (MLPA) to identify pathogenic copy‑number variants in genes critical for acute lymphoblastic leukemia classification and management. This technique offers single‑exon resolution with 99.9% sensitivity, surpassing conventional FISH or chromosomal microarray.
| Feature | Our Test (MLPA) | Closest Alternative (FISH/CMA) |
|---|---|---|
| Analytical Precision | Single‑exon resolution; 99.9% sensitivity | Limited to known probe targets; lower resolution |
| Turnaround Time | 9–10 working days | 7–14 days (often longer for comprehensive arrays) |
| Regulatory Compliance | ISO 9001:2015, DHA Licensed | Variable; may lack current UAE accreditation |
Physician Insight & Safety Protocols
“As your consulting clinical geneticist, I emphasize that this genetic result must be interpreted within the full clinical context, including complete blood counts, bone marrow morphology, and immunophenotyping. A positive finding identifies a prognostic or therapeutic target but should never replace a comprehensive specialist evaluation. Please arrange a dedicated consultation with your hematologist‑oncologist to integrate this information into a personalized care pathway.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
⚠️ Medication Safety Advisory
Do not discontinue any prescribed medication without first consulting your doctor. This test does not replace continuous clinical monitoring.
Important Exclusion Criteria & Emergency Red Flags
- This test is not indicated for pre‑surgical clearance, pregnancy‑related screening, or travel certificates without a formal doctor’s prescription.
- Individuals with active bleeding disorders or anticoagulant therapy must consult their physician before sample collection.
- Red Flags: If you experience unexplained fever, severe bleeding, sudden bone pain, or neurological symptoms, go to the nearest emergency department immediately – these may signal disease progression or complications.
Patient FAQ & Clinical Guidance
1. What is the purpose of the ALL Deletion/Duplication Panel?
This MLPA‑based panel identifies pathogenic deletions or duplications in genes linked to acute lymphoblastic leukemia, guiding precise diagnosis and personalized treatment selection.
2. How is the sample collected and where must it be taken?
Hospital Extraction Only – Sample collection is conducted strictly within an accredited hospital facility; mobile home phlebotomy is disabled for safety. A certified phlebotomist collects bone marrow aspirate or peripheral blood using strict sterile technique.
3. Will my insurance cover the cost and how can I check?
Most UAE health plans cover medically indicated genetic testing; send your Emirates ID and policy number via WhatsApp to +971545488731 for immediate direct billing verification.
UAE Regulatory & Data Privacy Adherence
This test fully complies with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Patient consent and clinical testing safety follow Federal Decree‑Law No. 4 of 2016 on Medical Liability. All data handling adheres to UAE health information governance standards.
Clinical & Logistical Metadata
| Test Name | ALL Panel Deletion/Duplication Detection |
| Price (AED) | 1,100 AED |
| Turnaround Time | 9–10 working days |
| Sample Type / Matrix | Hospital Extraction Only – Sample collection is conducted strictly within an accredited hospital facility; mobile home phlebotomy is disabled for safety. |
| Methodology Used | Multiplex Ligation-Dependent Probe Amplification (MLPA) |
| ICD-10-CM Code | C91.00 |
| LOINC Code | 88638-3 |
| DHA Facility License & Laboratory Address | License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE (DNA Labs UAE) |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians